Asia-Pacific markets are set to open mostly higher following Wall Street's rally ahead of U.S. election results. Investors are advised to monitor the dollar closely, as its strength may indicate market movements, particularly if Trump wins, which could lead to volatility in oil prices and potential tariff discussions. Conversely, a Harris victory may prompt buying opportunities amid anticipated market dips.
AstraZeneca shares plummeted 8.4% to a seven-month low following reports that senior executives in China may be involved in a significant insurance fraud case. The investigation, which includes multiple Chinese authorities, centers on allegations of faked prescriptions for the lung cancer drug Tagrisso. The company is cooperating with the investigation while maintaining that its operations in China continue.
Revvity, Inc. (formerly PerkinElmer, Inc.) focuses on developing and marketing measuring devices and analytical instruments across various sectors, including healthcare and environmental research. The company's net sales are primarily derived from medical diagnostic devices (61%) and analytical instruments (39%), with significant revenue coming from the United States (46.7%) and China (14.4%).
Revvity, Inc. (formerly PerkinElmer, Inc.) focuses on developing and marketing measuring devices and analytical instruments across various sectors, including healthcare and environmental research. The company generates 61% of its net sales from medical diagnostic devices and 39% from analytical instruments. Geographically, 46.7% of sales come from the United States, followed by China at 14.4%, the United Kingdom at 4.1%, and other regions at 34.8%.
UBS Asset Management maintains an overweight stance on global equities and the USD, citing strong earnings potential despite elevated valuations. Emerging markets are also favored due to positive earnings and political shifts in China, while Europe and Japanese government bonds are underweighted due to economic challenges. The outlook for corporate bonds remains neutral, with high yield bonds in Europe and Asia offering better valuations.
As the US election approaches, investors should brace for significant market volatility, with opportunities in equities, bonds, and gold. Regardless of the election outcome, US equities are expected to rise, driven by benign growth and AI support, while elevated bond yields present a chance to lock in attractive rates. Gold is anticipated to gain further, with a sharper rise expected if Trump wins, while a Harris victory may lead to a steadier climb.
At the seventh China International Import Expo (CIIE), global companies showcased innovative technologies, including Siemens Healthineers' MAGNETOM Terra.X MRI equipment and Michelin's lunar exploration tires. Startups like Vertaxi presented eVTOL aircraft for various applications, while Shift Robotics introduced motor-powered shoes for enhanced mobility. China's rise in the global innovation landscape is underscored by its 11th place ranking in the Global Innovation Index 2024, reflecting a shift towards quality-oriented growth.
UBS indicates that conditions are favorable for a year-end rally in US equities, driven by the resolution of election uncertainties and stable economic indicators, including strong consumer spending and job growth. However, risks such as potential election delays and inflation concerns could impact market momentum. The Federal Reserve's anticipated rate cuts and global fiscal support may further bolster investor confidence, positioning the market for potential gains.
UBS indicates that conditions are favorable for a year-end rally in US equities, driven by the resolution of election uncertainties and stable economic indicators, including strong consumer spending and job growth. However, risks such as potential election delays and inflation concerns could impact market momentum. The Federal Reserve's anticipated rate cuts and global fiscal support may further bolster investor confidence, positioning the market for potential gains.
The Online Medicine market is set for significant growth from 2024 to 2031, driven by key players like Google, Apple, and Tencent. The analysis covers market dynamics, segmentation by product types and applications, and regional insights, highlighting strategies such as acquisitions and product launches that enhance competitive positioning. Comprehensive forecasts and historical data provide valuable insights for strategic decision-making in the medical sector.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.